Ignite Creation Date:
2025-12-25 @ 2:15 AM
Ignite Modification Date:
2025-12-26 @ 4:57 PM
Study NCT ID:
NCT01236560
Status:
COMPLETED
Last Update Posted:
2024-02-20
First Post:
2010-11-05
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Vorinostat, Temozolomide, or Bevacizumab in Combination With Radiation Therapy Followed by Bevacizumab and Temozolomide in Young Patients With Newly Diagnosed High-Grade Glioma
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-01-26
Start Date Type:
ACTUAL
Primary Completion Date:
2023-06-30
Primary Completion Date Type:
ACTUAL
Completion Date:
2023-12-31
Completion Date Type:
ACTUAL
First Submit Date:
2010-11-05
First Submit QC Date:
None
Study First Post Date:
2010-11-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-02-14
Results First Submit QC Date:
None
Results First Post Date:
2020-06-22
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-01-25
Last Update Post Date:
2024-02-20
Last Update Post Date Type:
ACTUAL